Suboptimal cardiovascular ultrasound imaging can produce transthoracic echocardiograms (TTEs) that are inconclusive, resulting in negative patient outcomes and financial implications such as added costs for more testing. See why cSound software-beamforming technology from GE Healthcare addresses these challenges to potentially lessen patient burden, lower costs and improve patient care.
Feb. 11, 2025 — UltraSight, a company committed to enhancing the efficiency and productivity of cardiac ultrasound ...
February 18, 2025 
May 30, 2024 — A recent study published in the European Heart Journal highlights the significant enhancements that the ...
May 30, 2024 
April 5, 2024 — Cardiawave SA, a French medtech company that has developed an innovative Non-Invasive focused Ultrasound ...
April 05, 2024 
August 24, 2023 —Royal Philips, a global leader in health technology, highlighted how it integrates AI in cardiac ...
August 24, 2023 
July 27, 2023 —UltraSight, a digital health pioneer transforming cardiac imaging through the power of artificial ...
July 27, 2023 
February 10, 2023 — GE HealthCare, a leading global precision care innovator, announced that it has signed an agreement ...
February 10, 2023 
Sudden cardiac arrest is a complex and challenging medical emergency because it can occur anywhere at any time and is ...
August 23, 2022 
August 9, 2022 — Butterfly Medical, an Israeli medical device company developing a novel minimally invasive solution to ...
August 09, 2022 
July 20, 2022 — Teleflex Incorporated, a leading global provider of medical technologies, announced the first patient ...
July 20, 2022 
Enhanced features on the Philips EPIQ CVx ultrasound system provide a next level photorealistic 3D rendering, making it ...
July 20, 2022